- BX517
-
- $31.00
-
2026-07-27
- CAS:850717-64-5
- Purity: 99.38%
- Supply Ability: 10g
|
| | BX517(PDK1 inhibitor2) Basic information |
| Product Name: | BX517(PDK1 inhibitor2) | | Synonyms: | BX-517;BX517(PDK1 inhibitor2);5-Ureido-3-[1-(pyrrol-2-yl)ethylidene]indolin-2-one;PDK1 Inhibitor 2;CS-1693;PDK1 Inhibitor II;BX-517;BX 517;Urea, [2,3-dihydro-2-oxo-3-[1-(1H-pyrrol-2-yl)ethylidene]-1H-indol-5-yl]- | | CAS: | 850717-64-5 | | MF: | C15H14N4O2 | | MW: | 282.3 | | EINECS: | | | Product Categories: | | | Mol File: | 850717-64-5.mol |  |
| | BX517(PDK1 inhibitor2) Chemical Properties |
| Boiling point | 572.431±50.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.431±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | storage temp. | Store at -20°C | | solubility | insoluble in H2O; insoluble in EtOH; ≥8.55 mg/mL in DMSO | | form | solid | | pka | 12.818±0.20(predicted) | | color | Light yellow to khaki | | InChI | 1S/C15H14N4O2/c1-8(11-3-2-6-17-11)13-10-7-9(18-15(16)21)4-5-12(10)19-14(13)20/h2-7,17H,1H3,(H,19,20)(H3,16,18,21)/b13-8- | | InChIKey | DFURSNCTQGJRRX-JYRVWZFOSA-N |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | BX517(PDK1 inhibitor2) Usage And Synthesis |
| Uses | BX-517 is a potent and selective inhibitor of PDK1 that binds to the ATP binding pocket of the protein (IC50 = 6 nM). | | Biological Activity | bx-517 is a potent and selective inhibitor of pdk1 that binds to the atp binding pocketof the protein (ic50 = 6 nm). bx-517 also blocks activation of akt in tumor cells with 10-fold more potent (ic50 = 0.1–1.0 μm) than its analogs tested at the highest dose tested (10 μm). [1] the phosphoinositide-dependent kinase-1 (pdk1) is a ser/thr kinase that is a crucial activator of a range of protein kinases in the agc kinase super-family that play key roles in the progression of cancer and for the activation of akt, s6 kinase, and protein kinase c. [2] | | references | 1. islam i, brown g, bryant j et al. indolinone based phosphoinositide-dependentkinase-1 (pdk1) inhibitors. part 2: optimization of bx-517. bioorg med chem lett.2007 jul 15;17(14):3819-25. 2. islam i, bryant j, chou yl etc. indolinone based phosphoinositide-dependent kinase-1 (pdk1)inhibitors. part 1: design, synthesis and biological activity. bioorg med chem lett. 2007 jul 15;17(14):3814-8. |
| | BX517(PDK1 inhibitor2) Preparation Products And Raw materials |
|